We will be hosting a webinar on Wednesday, July 27th, on the topic “Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies”.

Join our Director of Commercial AI Services, Dr. Trevor McKee, as he discusses the role of Pathology and AI in streamlining the drug approval process. Trevor will focus on one specific example - detecting hepatocellular hypertrophy in preclinical safety testing. We also discuss its relevance to identifying other signs of toxicity, and how this tool, as part of our AI service, can be implemented to streamline pathologist workflows and give confidence in results.

‍

When

‍July 27, 2022
16:00 - 17:00 GMT+1 | 11:00 – 12:00 EDT | 8:00 – 9:00 PDT

Speaker:

Dr. Trevor McKee,
Director of Commercial AI Services for Research Pathology.

‍

To register for the event, click here.